Global Recombinant Peptides Market Research Report 2011-2023

Publisher Name :
Date: 14-Apr-2018
No. of pages: 83

Summary

The global Recombinant Peptides market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

- Glucagon

- Calcitonin

- Others

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

- Sandoz Pharma

- Stada Arzneimittel

- Amgen

- Hospira

- Actavis

- Cipla Ltd.

- Wockhardt Ltd.

- Biocon Ltd.

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

- Oncology

- Blood Disorders

- Infectious Diseases

- Autoimmune Diseases

- Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

- Asia-Pacific

- North America

- Europe

- South America

- Middle East & Africa

Global Recombinant Peptides Market Research Report 2011-2023

Table of Contents

1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Glucagon
1.2.1.2 Calcitonin
1.2.1.3 Others
1.2.2 by Application
1.2.2.1 Oncology
1.2.2.2 Blood Disorders
1.2.2.3 Infectious Diseases
1.2.2.4 Autoimmune Diseases
1.2.2.5 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Glucagon Market, 2011-2016
4.1.2 Calcitonin Market, 2011-2016
4.1.3 Others Market, 2011-2016
4.2 Market Forecast
4.2.1 Glucagon Market Forecast, 2017-2022
4.2.2 Calcitonin Market Forecast, 2017-2022
4.2.3 Others Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Oncology Market, 2011-2016
5.1.2 Blood Disorders Market, 2011-2016
5.1.3 Infectious Diseases Market, 2011-2016
5.1.4 Autoimmune Diseases Market, 2011-2016
5.1.5 Others Market, 2011-2016
5.2 Market Forecast
5.2.1 Oncology Market Forecast, 2017-2022
5.2.2 Blood Disorders Market Forecast, 2017-2022
5.2.3 Infectious Diseases Market Forecast, 2017-2022
5.2.4 Autoimmune Diseases Market Forecast, 2017-2022
5.2.5 Others Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2011-2016
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2011-2016
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2011-2016
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2011-2016
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2011-2016
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Sandoz Pharma
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Stada Arzneimittel
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Amgen
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Hospira
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Actavis
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 Cipla Ltd.
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 Wockhardt Ltd.
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Biocon Ltd.
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
9 Conclusion

List of Tables

Table Product Specifications of Recombinant Peptides
Table Products Segment of Recombinant Peptides
Table Glucagon Overview
Table Calcitonin Overview
Table Others Overview
Table Global Recombinant Peptides Market by Type, 2011-2022 (USD Million)
Table Application Segment of Recombinant Peptides
Table Oncology Overview
Table Blood Disorders Overview
Table Infectious Diseases Overview
Table Autoimmune Diseases Overview
Table Others Overview
Table Global Recombinant Peptides Market by Application, 2011-2022 (USD Million)
Table Global Recombinant Peptides Market by Region, 2011-2022 (USD Million)
Table Cost of Recombinant Peptides
Table Market Dynamics
Table Policy of Recombinant Peptides
Table GDP of Major Countries
Table Glucagon CAGR by Revenue and Volume, 2011-2016
Table Calcitonin CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016
Table Glucagon CAGR by Revenue and Volume, 2012-2022
Table Calcitonin CAGR by Revenue and Volume, 2012-2022
Table Others CAGR by Revenue and Volume, 2012-2022
Table Oncology CAGR by Revenue and Volume, 2011-2016
Table Blood Disorders CAGR by Revenue and Volume, 2011-2016
Table Infectious Diseases CAGR by Revenue and Volume, 2011-2016
Table Autoimmune Diseases CAGR by Revenue and Volume, 2011-2016
Table Others CAGR by Revenue and Volume, 2011-2016

List of Figures

Figure Recombinant Peptides Picture
Figure Industry Chain Structure of Recombinant Peptides
Figure SWOT of Recombinant Peptides
Figure Glucagon Market Size and Growth, 2011-2016 (USD Million)
Figure Glucagon Market Size and Growth, 2011-2016 (in Volume)
Figure Calcitonin Market Size and Growth, 2011-2016 (USD Million)
Figure Calcitonin Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Glucagon Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Glucagon Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Calcitonin Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Calcitonin Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Oncology Market Size and Growth, 2011-2016 (USD Million)
Figure Oncology Market Size and Growth, 2011-2016 (in Volume)
Figure Blood Disorders Market Size and Growth, 2011-2016 (USD Million)
Figure Blood Disorders Market Size and Growth, 2011-2016 (in Volume)
Figure Infectious Diseases Market Size and Growth, 2011-2016 (USD Million)
Figure Infectious Diseases Market Size and Growth, 2011-2016 (in Volume)
Figure Autoimmune Diseases Market Size and Growth, 2011-2016 (USD Million)
Figure Autoimmune Diseases Market Size and Growth, 2011-2016 (in Volume)
Figure Others Market Size and Growth, 2011-2016 (USD Million)
Figure Others Market Size and Growth, 2011-2016 (in Volume)
Figure Oncology Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Oncology Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Blood Disorders Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Blood Disorders Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Infectious Diseases Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Infectious Diseases Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Autoimmune Diseases Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Autoimmune Diseases Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Others Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Others Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Recombinant Peptides Market Concentration by Region
Figure Marketing Channels Overview
  • Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 62
    Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 Summary According to the recently published report 'Transmembrane Prolyl 4 Hydroxylase - Pipeline Review, H2 2018'; Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) pipeline Target constitutes close to 9 molecules. Transmembrane Prolyl 4 Hydroxylase (Hypoxia Ind......
  • CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 60
    CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H2 2018 Summary CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) pipeline Target constitutes close to 18 molecules. Out of which approximately 15 molecules are developed by companies and remaining by the universities/ins......
  • Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 128
    Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) pipeline Target constitutes close to 27 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the universities/institutes. The latest report Histone Deacetylase 2 - P......
  • Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 150
    Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary According to the recently published report 'Histone Deacetylase 1 - Pipeline Review, H2 2018'; Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) pipeline Target constitutes close to 29 molecules. Out of which approximately 24 molecules are developed by companies and remaining by the universities/institutes. Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 i......
  • Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 72
    Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H2 2018 Summary Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Myostatin also known as growth differentiation factor 8 or GDF-8 is a myokine a protein produced and released by myocytes. This protein is part of the transforming growth factor beta (TGFß) superfamily. Myostatin is found almost in muscles used for movement, where it is active both before and after birth. This p......
  • Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 32
    Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H2 2018 Summary Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Cathepsin B (CatB) is an enzymatic protein belonging to the peptidase. It promotes hydrolysis of proteins with broad specificity for peptide bonds. It cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates. In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-......
  • Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 73
    Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018 Summary According to the recently published report 'Hepatocyte Growth Factor - Pipeline Review, H2 2018'; Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) pipeline Target constitutes close to 14 molecules. Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Hepatocyte growth factor (HGF) is a paracrine cellular growth an......
  • Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 53
    Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H2 2018 Summary Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Glial -derived neurotrophic factor is a member of the cysteine-knot superfamily of growth factors. It promotes the survival and differentiation of dopaminergic neurons and was able to prevent apoptosis of motor neurons. The mature form of the protein is a lig......
  • Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2018
    Published: 18-Sep-2018        Price: US 3500 Onwards        Pages: 53
    Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H2 2018 Summary Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. The latest report Nicotinamide Phosphoribos......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs